Company Filing History:
3 out of 10 
1 out of 24 
1 out of 832,880 Years Active: 1997-2000
Title: Kristen L Unverzagt: Innovator in Hematology
Introduction
Kristen L Unverzagt is a prominent inventor based in Palatine, IL (US). She has made significant contributions to the field of hematology, particularly through her innovative work on genetically altered human neutrophil precursor cells. With a total of 5 patents to her name, her research has the potential to impact medical treatments and therapies.
Latest Patents
Among her latest patents, Kristen has developed a composition comprising genetically altered human neutrophil precursor cells. This composition includes at least about 16% human myeloblasts and promyelocytes derived from neutrophil progenitor cells obtained from peripheral blood, bone marrow, or cord blood. Additionally, it contains less than about 5% colony-forming units (CFU) of at least about 50 cells. Another notable patent involves in-vitro-derived human neutrophil precursor cells, which have at least 37% myeloblasts and promyeloblasts, along with hematopoietic cell suspensions that include these precursor cells and at least one hematopoietic growth factor.
Career Highlights
Kristen has worked with Nexell Therapeutics Inc., where she has furthered her research and development efforts. Her work has been instrumental in advancing the understanding of human neutrophil precursor cells and their applications in medical science.
Collaborations
Throughout her career, Kristen has collaborated with notable professionals in her field, including Stephen L Smith and James G Bender. These collaborations have enriched her research and contributed to her innovative projects.
Conclusion
Kristen L Unverzagt stands out as a leading inventor in the field of hematology, with her groundbreaking patents paving the way for future advancements in medical treatments. Her dedication to research and innovation continues to inspire others in the scientific community.